2171.HK
CARsgen Therapeutics Holdings Limited
HKSEHKDEQUITY
Healthcare
DELAYED
Last price
13.21
▼ 0.32 (2.37%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
13.90
Prev close
13.53
Day high
13.62
Day low
13.21
Volume
1.82M
Market cap
$7.53B
P/E (TTM)
—
52W range
10.87 – 28.60
Day trading desk
Gap from prior close
+2.73%
Prior close 13.53
VWAP
13.31
-0.74% from price
Relative volume
0.83×
Normal
Session range
5.22%
13.21 – 13.90
Position in range
0%
Near session low
ATR (14D)
0.97
7.32% of price
Prior day high
14.25
PDH
Prior day low
13.39
PDL
Bid / ask spread
—
Quote not published
Session volume
4.12M
Avg 4.98M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-8.20%
-7.0%
1M
-10.56%
-13.9%
3M
-24.56%
-27.0%
6M
-8.26%
-20.2%
YTD
-10.07%
-22.0%
1Y
-37.27%
-57.4%
3Y
+27.02%
-48.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 2171.HK open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
188.08M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Dec 22, 25 | Guo (Huaqing) Director (Non-Executive) |
BUY | 20.00K | $38.38K | Direct |
| Dec 19, 25 | Guo (Huaqing) Director (Non-Executive) |
BUY | 30.00K | $58.18K | Direct |
| Dec 18, 25 | Guo (Huaqing) Director (Non-Executive) |
BUY | 18.00K | $33.59K | Direct |
| Dec 15, 25 | Guo (Huaqing) Director (Non-Executive) |
BUY | 30.00K | $57.75K | Direct |
| Dec 12, 25 | Guo (Huaqing) Director (Non-Executive) |
BUY | 18.50K | $36.43K | Direct |
| Dec 10, 25 | Guo (Huaqing) Director (Non-Executive) |
BUY | 30.00K | $65.16K | Direct |
| Dec 8, 25 | Guo (Huaqing) Director (Non-Executive) |
BUY | 10.00K | $22.75K | Direct |
| Nov 24, 25 | Guo (Huaqing) Director (Non-Executive) |
BUY | 30.00K | $63.19K | Direct |
| Nov 19, 25 | Guo (Huaqing) Director (Non-Executive) |
BUY | 36.50K | $81.00K | Direct |
| Nov 18, 25 | Guo (Huaqing) Director (Non-Executive) |
BUY | 30.00K | $67.52K | Direct |
| Nov 12, 25 | Guo (Huaqing) Director (Non-Executive) |
BUY | 50.00K | $110.66K | Direct |
| Nov 10, 25 | Guo (Huaqing) Director (Non-Executive) |
BUY | 30.00K | $63.29K | Direct |
| Nov 6, 25 | Guo (Huaqing) Director (Non-Executive) |
BUY | 70.00K | $133.24K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Guo (Huaqing) |
Director (Non-Executive) | 2.48M | Acquisition |
Fundamentals
Market cap$7.53B
Enterprise value$5.60B
Revenue (TTM)$136.62M
Gross profit$92.60M
EBITDA$-219.11M
Net income$-89.18M
EPS (TTM)$-0.21
Free cash flow$-57.99M
Total cash$1.40B
Total debt$71.99M
Book value / share$2.50
Shares outstanding569.83M
Float332.48M
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E5.76
PEG ratio—
Price / sales—
Price / book5.28
EV / revenue41.01
EV / EBITDA-25.57
Gross margin67.78%
Operating margin-115.21%
Profit margin-65.28%
Return on equity-9.56%
Return on assets-8.99%
Debt / equity6.59
Current ratio7.07
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $125.66M | $39.42M | $0 | $0 | +218.7% |
| Operating revenue | $125.66M | $39.42M | $0 | $0 | +218.7% |
| Cost of revenue | $45.71M | $24.68M | $0 | $0 | +85.2% |
| Gross profit | $79.95M | $14.75M | $0 | $0 | +442.1% |
| Research & development | $245.36M | $466.19M | $661.66M | $680.30M | -47.4% |
| Selling, general & admin | $26.07M | $52.02M | $42.82M | $46.82M | -49.9% |
| Total operating expense | $308.25M | $588.45M | $784.68M | $802.28M | -47.6% |
| Operating income | -$228.31M | -$573.70M | -$784.68M | -$802.28M | +60.2% |
| Net interest income | $7.91M | $36.20M | $68.13M | $12.04M | -78.2% |
| Pre-tax income | -$102.91M | -$797.79M | -$747.39M | -$890.95M | +87.1% |
| Tax provision | $0 | $346.00K | $407.00K | $1.29M | -100.0% |
| Net income | -$97.86M | -$798.13M | -$747.79M | -$892.25M | +87.7% |
| Net income to common | -$97.86M | -$798.13M | -$747.79M | -$892.25M | +87.7% |
| Basic EPS | -0.18 | -1.44 | -1.34 | -1.62 | +87.5% |
| Diluted EPS | -0.18 | -1.44 | -1.34 | -1.62 | +87.5% |
| EBIT | -$96.01M | -$792.07M | -$742.72M | -$875.43M | +87.9% |
| EBITDA | -$66.51M | -$712.52M | -$655.33M | -$793.90M | +90.7% |
| Basic shares | 552.06M | 552.88M | 556.13M | 550.77M | -0.1% |
| Diluted shares | 552.06M | 552.88M | 556.13M | 550.77M | -0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.11B | $1.48B | $1.85B | $2.27B | -24.9% |
| Cash & short-term investments | $1.11B | $1.48B | $1.85B | $2.27B | -24.9% |
| Accounts receivable | $15.55M | $8.77M | $0 | — | +77.4% |
| Inventory | $7.14M | $6.93M | $683.00K | $0 | +3.1% |
| Total current assets | $1.18B | $1.53B | $1.87B | $2.30B | -23.0% |
| Property, plant & equipment | $92.27M | $118.38M | $356.23M | $436.86M | -22.1% |
| Goodwill & intangibles | $7.31M | $9.26M | $15.13M | $21.11M | -21.1% |
| Total assets | $1.29B | $1.67B | $2.26B | $2.76B | -22.8% |
| Total current liabilities | $205.46M | $254.01M | $196.22M | $171.00M | -19.1% |
| Current debt | $0 | $20.29M | $2.52M | $4.85M | -100.0% |
| Long-term debt | $0 | $68.85M | $0 | $2.52M | -100.0% |
| Total debt | $61.18M | $166.42M | $85.22M | $119.44M | -63.2% |
| Total liabilities | $512.80M | $616.33M | $455.51M | $289.64M | -16.8% |
| Retained earnings | -$9.09B | -$8.99B | -$8.19B | -$7.44B | -1.1% |
| Shareholder equity | $783.32M | $1.06B | $1.80B | $2.47B | -25.9% |
| Working capital | $972.63M | $1.28B | $1.68B | $2.13B | -23.8% |
| Net tangible assets | $776.01M | $1.05B | $1.79B | $2.45B | -25.9% |
| Shares issued | 578.12M | 571.67M | 575.64M | 572.63M | +1.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$102.91M | -$797.79M | -$747.39M | -$890.95M | +87.1% |
| Depreciation & amortisation | $29.50M | $79.56M | $87.39M | $81.53M | -62.9% |
| Stock-based compensation | $25.28M | $9.09M | $14.46M | $43.99M | +178.2% |
| Change in working capital | -$70.00M | $53.09M | $211.38M | $43.48M | -231.8% |
| Operating cash flow | -$236.90M | -$409.69M | -$454.94M | -$643.05M | +42.2% |
| Capital expenditure | -$6.13M | -$19.57M | -$9.55M | -$138.61M | +68.7% |
| Investing cash flow | -$2.88M | $12.52M | $39.25M | $2.39B | -123.0% |
| Share buybacks | -$115.28M | -$50.27M | $0 | — | -129.3% |
| Financing cash flow | -$111.72M | $18.46M | -$22.14M | -$236.51M | -705.3% |
| Free cash flow | -$243.03M | -$429.26M | -$464.48M | -$781.66M | +43.4% |
| End cash position | $1.12B | $1.48B | $1.85B | $2.27B | -24.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $1.11B | $1.26B | $1.48B | -11.9% |
| Cash & short-term investments | $1.11B | $1.26B | $1.48B | -11.9% |
| Accounts receivable | $15.55M | $18.55M | $8.77M | -16.1% |
| Inventory | $7.14M | $11.12M | $6.93M | -35.8% |
| Total current assets | $1.18B | $1.38B | $1.53B | -14.6% |
| Property, plant & equipment | $92.27M | $110.88M | $118.38M | -16.8% |
| Goodwill & intangibles | $7.31M | $3.58M | $9.26M | +104.3% |
| Total assets | $1.29B | $1.51B | $1.67B | -14.6% |
| Total current liabilities | $205.46M | $213.80M | $254.01M | -3.9% |
| Current debt | $0 | $0 | $20.29M | — |
| Long-term debt | $0 | $0 | $68.85M | — |
| Total debt | $61.18M | $69.25M | $166.42M | -11.7% |
| Total liabilities | $512.80M | $551.26M | $616.33M | -7.0% |
| Retained earnings | -$9.09B | -$9.06B | -$8.99B | -0.2% |
| Shareholder equity | $783.32M | $962.13M | $1.06B | -18.6% |
| Working capital | $972.63M | $1.17B | $1.28B | -16.6% |
| Net tangible assets | $776.01M | $958.56M | $1.05B | -19.0% |
| Shares issued | 578.12M | 575.90M | 571.67M | +0.4% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | -0.18 | 2 | $311.34M | +147.8% |
| Next year | 0.04 | 2 | $785.99M | +152.5% |
Analyst targets & ownership
Mean target$18.33
High target$22.82
Low target$13.84
Implied upside38.75%
Analyst count2
ConsensusHOLD
Strong buy / Buy0 / 1
Hold0
Sell / Strong sell1 / 0
Held by insiders36.68%
Held by institutions4.26%
Institutions holding26
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
14.63
-9.73% from price
SMA 20
14.24
-7.24% from price
SMA 50
14.78
-10.60% from price
SMA 100
17.35
-23.85% from price
SMA 200
16.51
-19.99% from price
EMA 12
14.31
-7.71% from price
EMA 26
14.56
-9.26% from price
EMA 50
15.12
-12.61% from price
RSI (14)
39.6
Neutral
MACD (12,26,9)
-0.24
Hist -0.10
ATR (14)
0.97
7.32% of price
Realised vol 30D
64.3%
Annualised
Bollinger upper
16.10
20, 2σ
Bollinger lower
12.39
20, 2σ
50 / 200 cross
Death
14.78 vs 16.51
Trend bias
Below 200
-19.99%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.09
Less volatile than market
Correlation to SPY
-0.02
Largely independent
Realised vol 30D
64.3%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-53.6%
Peak to trough
Max drawdown 5Y
-95.2%
Peak to trough
ATR 14
0.97
7.32% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Micron's Big AI Test Is Coming This Week
GuruFocus.com · 3m ago
Alibaba Slides as $10.2 Billion AI Sale Dilutes Investors
GuruFocus.com · 4m ago
Media Advisory: Infrastructure Announcement in Scarborough
CNW Group · 4m ago
Jersey Mike's Subs Same-Store Sales Growth More Durable Than Peers, RBC Says
MT Newswires · 5m ago
HearingLife Introduces Oticon Reveal, the World's First Dual AI-Powered Hearing Aid
PR Newswire · 5m ago
France readies high school phone ban for next month
AFP · 6m ago
Announcement on the registration of share capital increase in Commercial Register
GlobeNewswire · 7m ago
DeepCura Unveils the Electronic Health Workforce (EHW) -- the Step Beyond the EHR
PR Newswire · 8m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.